Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid prophylaxis in adult hip and knee arthroplasty
ChiCTR2300067584Phase 4Completed
- Sponsor
- Shanghai East Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of contezolid in surgical site infection (SSI), sponsored by Shanghai East Hospital. Primary endpoints: Clinical effect, Blood drug concentration and 2 more. Started Jan 2023; status: completed.
02
Drugs
contezolid
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on ChiCTR2300067584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067584.